Na؉ /Cl ؊ -dependent neurotransmitter transporters form constitutive oligomers, the significance of which is not known. In soluble proteins, leucine heptad repeats drive dimerization; the rat ␥-aminobutyric acid transporter GAT-1 (rGAT) contains a motif reminiscent of a leucine heptad repeat in the second transmembrane helix (TM2). We substituted leucine residues in TM2 of rGAT by alanine and tested the ability of the resulting mutants to form oligomers by three methods of Fö rster resonance energy transfer (FRET) microscopy. Replacement of one leucine (L97A) resulted in considerable loss of energy transfer, replacing two or more ablated it completely. Furthermore, intracellular trapping increased with the number of leucine substitutions. Only rGAT-L97A reached the cell surface to a sufficient amount such that, in intact cells, it was indistinguishable from wild type rGAT with respect to substrate transport, binding of inhibitors, and regulation by protein kinase C. However, in membrane vesicles prepared from transfected cells, all mutants were still functional. In addition, FRET was readily detected during maturation of wild type rGAT, when the bulk of the protein resided in the endoplasmic reticulum. Hence, our findings strongly argue for a role of oligomer formation during biosynthesis and subsequent delivery of the multimer from the endoplasmic reticulum to the plasma membrane.
Naϩ /Cl Ϫ -dependent neurotransmitter transporters (e.g. the transporters for dopamine, serotonin, or GABA) 1 retrieve neurotransmitters from the synaptic cleft into the presynaptic specialization (1). The medical relevance of these proteins is obvious; for instance, it has long been known that antidepressant drugs block the transporter for norepinephrine and serotonin (2). Likewise, tiagabine, an inhibitor of GABA transport, is used as an anticonvulsant in the treatment of epileptic seizures (3). Transporters support bidirectional flux of substrate, i.e. not only do they mediate influx of substrate but they also allow for non-exocytotic release of substrate (4). Compounds that induce reverse transport enjoy widespread popularity among illicit drug users; this is particularly true for amphetamine and its congeners, including ecstasy.Increasing evidence suggests that neurotransmitter transporters are oligomers (5, 6). Constitutive oligomerization has been visualized in intact cells by FRET microscopy (7); the oligomeric nature of neurotransmitter transporters has also been demonstrated by other, more disruptive, approaches, e.g. co-immunoprecipitation from detergent extracts and crosslinking (8 -10) and by freeze-fracture electron microscopy (11). However, the functional role of oligomer formation remains enigmatic. The hypothesis has been formulated that neurotransmitter transporters function in a manner analogous to ligand-gated ion channels, as binding of substrate induces an ion current (12-14). There is still an ongoing debate whether the GAT operates in a channel-like mode (15, 16) or according to the conservative "alternating ac...